UK markets open in 7 hours 26 minutes
NIKKEI 225
38,471.20 -761.60 (-1.94%) HANG SENG
16,248.97 -351.49 (-2.12%) CRUDE OIL
85.28 -0.08 (-0.09%) GOLD FUTURES
2,399.70 -8.10 (-0.34%) DOW
37,798.97 +63.86 (+0.17%) Bitcoin GBP
51,369.42 +460.83 (+0.91%)
Quest Diagnostics Incorporated (QDI.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:01AM CEST
| Previous close | 121.30 |
| Open | 120.90 |
| Bid | 120.65 x 30000 |
| Ask | 120.75 x 30000 |
| Day's range | 120.90 - 120.90 |
| 52-week range | 113.65 - 133.40 |
| Volume | |
| Avg. volume | 9 |
| Market cap | 13.427B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 17.17 |
| EPS (TTM) | 7.04 |
| Earnings date | 23 Apr 2024 |
| Forward dividend & yield | 2.77 (2.28%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | 157.67 |
ZacksEarnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksQuest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
ZacksMyriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
© 2024 Yahoo. All rights reserved.